29
Views
142
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition

, , , &
Pages 8428-8436 | Received 03 Jul 2001, Accepted 20 Sep 2001, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Pengcheng Wang, Wenze Xun, Tianyu Han & Zhujun Cheng. (2020) FAIM-S functions as a negative regulator of NF-κB pathway and blocks cell cycle progression in NSCLC cells. Cell Cycle 19:24, pages 3458-3467.
Read now
Jae-Hwan Yoon, Jong-Woon Shin, Thu-Huyen Pham, Youn-Jin Choi, Hyung-Won Ryu, Sei-Ryang Oh, Jae-Wook Oh & Do-Young Yoon. (2020) Methyl lucidone induces apoptosis and G2/M phase arrest via the PI3K/Akt/NF-κB pathway in ovarian cancer cells. Pharmaceutical Biology 58:1, pages 51-59.
Read now
Elizabeth G. Demicco, Kathryn T. Kavanagh, Raphaëlle Romieu-Mourez, Xiaobo Wang, Sangmin R. Shin, Esther Landesman-Bollag, David C. Seldin & Gail E. Sonenshein. (2005) RelB/p52 NF-κB Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor IκB-α Expression and Promote Carcinogenesis of the Mammary Gland. Molecular and Cellular Biology 25:22, pages 10136-10147.
Read now
Shravanti Rampalli, L. Pavithra, Altaf Bhatt, Tapas K. Kundu & Samit Chattopadhyay. (2005) Tumor Suppressor SMAR1 Mediates Cyclin D1 Repression by Recruitment of the SIN3/Histone Deacetylase 1 Complex. Molecular and Cellular Biology 25:19, pages 8415-8429.
Read now
M. A. Christine Pratt, Tanya E. Bishop, Dawn White, Gordon Yasvinski, Michel Ménard, Min Ying Niu & Robert Clarke. (2003) Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence. Molecular and Cellular Biology 23:19, pages 6887-6900.
Read now
Raphaëlle Romieu-Mourez, Dong W. Kim, Sang Min Shin, Elizabeth G. Demicco, Esther Landesman-Bollag, David C. Seldin, Robert D. Cardiff & Gail E. Sonenshein. (2003) Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors. Molecular and Cellular Biology 23:16, pages 5738-5754.
Read now
Sonia Rocha, Anthea M. Martin, David W. Meek & Neil D. Perkins. (2003) p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1. Molecular and Cellular Biology 23:13, pages 4713-4727.
Read now

Articles from other publishers (134)

Wenfei Pan, Limei Deng, Haitao Wang & Vivien Ya-Fan Wang. (2022) Atypical IκB Bcl3 enhances the generation of the NF-κB p52 homodimer. Frontiers in Cell and Developmental Biology 10.
Crossref
Hui Liu, Lin Zeng, Yang Yang, Chunlei Guo & Hui Wang. (2022) Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation. Frontiers in Immunology 13.
Crossref
Xintong Peng, Yanling Zhou, Yongguang Tao & Shuang Liu. (2021) Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein–Barr Virus Infection. Pathogens 10:9, pages 1113.
Crossref
Jiaoyu Ai, Sonja M. Wörmann, Kıvanç Görgülü, Mireia Vallespinos, Sladjana Zagorac, Sonia Alcala, Nan Wu, Derya Kabacaoglu, Alexandra Berninger, Diego Navarro, Ezgi Kaya-Aksoy, Dietrich A. Ruess, Katrin J. Ciecielski, Marlena Kowalska, Ihsan Ekin Demir, Güralp O. Ceyhan, Irina Heid, Rickmer Braren, Marc Riemann, Sabrina Schreiner, Samuel Hofmann, Maria Kutschke, Martin Jastroch, Julia Slotta-Huspenina, Alexander Muckenhuber, Anna Melissa Schlitter, Roland M. Schmid, Katja Steiger, Kalliope N. Diakopoulos, Marina Lesina, Bruno SainzJr.Jr. & Hana Algül. (2021) Bcl3 Couples Cancer Stem Cell Enrichment With Pancreatic Cancer Molecular Subtypes. Gastroenterology 161:1, pages 318-332.e9.
Crossref
Zahra Eskandari, Fatemeh Bahadori, Melda Altıkatoglu Yapaoz, Vildan Betul Yenigun, Mert Celikten, Abdurrahim Kocyigit & Hayat Onyuksel. (2021) Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles. European Journal of Pharmaceutical Sciences 162, pages 105830.
Crossref
Fernando Gómez-Chávez, Dolores Correa, Pilar Navarrete-Meneses, Juan Carlos Cancino-Diaz, Mario Eugenio Cancino-Diaz & Sandra Rodríguez-Martínez. (2021) NF-κB and Its Regulators During Pregnancy. Frontiers in Immunology 12.
Crossref
Jan Pawlonka, Beata Rak & Urszula Ambroziak. (2021) The regulation of cyclin D promoters – review. Cancer Treatment and Research Communications 27, pages 100338.
Crossref
Daniel J Turnham, William W Yang, Julia Davies, Athina Varnava, Anne J Ridley, R Steven Conlan & Richard W E Clarkson. (2020) Bcl-3 promotes multi-modal tumour cell migration via NF-κB1 mediated regulation of Cdc42. Carcinogenesis 41:10, pages 1432-1443.
Crossref
Danny N Legge, Adam C Chambers, Christopher T Parker, Penny Timms, Tracey J Collard & Ann C Williams. (2020) The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis. Carcinogenesis 41:3, pages 249-256.
Crossref
Tracey Collard, Hafsah Fallatah, Alexander Greenhough, Christos Paraskeva & Ann Williams. (2020) BCL‑3 promotes cyclooxygenase‑2/prostaglandin�E2 signalling in colorectal cancer. International Journal of Oncology.
Crossref
Cong Tang & Guodong Zhu. (2019) Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways. Current Stem Cell Research & Therapy 14:3, pages 219-225.
Crossref
Kei Otsuka, Asuka Takehara, Natsuko Chiba & Yasuhisa Matsui. (2018) Identification of KLF9 and BCL3 as transcription factors that enhance reprogramming of primordial germ cells. PLOS ONE 13:10, pages e0205004.
Crossref
Yue Zou, Mohammad M. Uddin, Sveta Padmanabhan, Yan Zhu, Pengli Bu, Ales Vancura & Ivana Vancurova. (2018) The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells. Journal of Biological Chemistry 293:40, pages 15483-15496.
Crossref
Kun Wang, Shuai Li, Yong Gao, Xiaobo Feng, Wei Liu, Rongjin Luo, Yu Song, Ji Tu, Yingle Liu & Cao Yang. (2018) BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages. Bone 114, pages 257-267.
Crossref
Matthew Tegowski & Albert Baldwin. (2018) Noncanonical NF-κB in Cancer. Biomedicines 6:2, pages 66.
Crossref
Paula Grondona, Philip Bucher, Klaus Schulze-Osthoff, Stephan Hailfinger & Anja Schmitt. (2018) NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. Biomedicines 6:2, pages 38.
Crossref
Mingfeng Shao, Zexiang Ren & Rongjun Zhang. (2018) MYBL2 protects against H9c2 injury induced by hypoxia via AKT and NF‑κB pathways. Molecular Medicine Reports.
Crossref
Vahid Jalili, Matteo Matteucci, Marco Masseroli & Stefano Ceri. (2017) Explorative visual analytics on interval-based genomic data and their metadata. BMC Bioinformatics 18:1.
Crossref
Nadine Gehrke, Marcus A. Wörns, Amrit Mann, Yvonne Huber, Nadine Hoevelmeyer, Thomas Longerich, Ari Waisman, Peter R. Galle & Jörn M. Schattenberg. (2016) Hepatic B cell leukemia-3 suppresses chemically-induced hepatocarcinogenesis in mice through altered MAPK and NF-κB activation. Oncotarget 8:34, pages 56095-56109.
Crossref
Vivien Ya-Fan Wang, Yidan Li, Daniel Kim, Xiangyang Zhong, Qian Du, Majid Ghassemian & Gourisankar Ghosh. (2017) Bcl3 Phosphorylation by Akt, Erk2, and IKK Is Required for Its Transcriptional Activity. Molecular Cell 67:3, pages 484-497.e5.
Crossref
Flávia R.M. da Silva, Tony F. Grassi, Joyce R. Zapaterini, Lucas T. Bidinotto & Luis F. Barbisan. (2017) Early-in-life dietary zinc deficiency and supplementation and mammary tumor development in adulthood female rats. The Journal of Nutritional Biochemistry 44, pages 71-79.
Crossref
S. Pasquereau, F. Al Moussawi, W. Karam, M. Diab Assaf, A. Kumar & G. Herbein. (2017) Cytomegalovirus, Macrophages and Breast Cancer. The Open Virology Journal 11:1, pages 15-27.
Crossref
Xi Chen, Xinwei Cao, Xiaohua Sun, Rong Lei, Pengfei Chen, Yongxu Zhao, Yuhang Jiang, Jie Yin, Ran Chen, Deji Ye, Qi Wang, Zhanjie Liu, Sanhong Liu, Chunyan Cheng, Jie Mao, Yingyong Hou, Mingliang Wang, Ulrich Siebenlist, Y Eugene Chin, Ying Wang, Liu Cao, Guohong Hu & Xiaoren Zhang. (2016) Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis. Cell Death & Disease 7:12, pages e2508-e2508.
Crossref
Paul A. Bruno, Alex Morriss-Andrews, Andrew R. Henderson, Charles L. BrooksIIIIII & Anna K. Mapp. (2016) A Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling. Angewandte Chemie International Edition 55:48, pages 14997-15001.
Crossref
Paul A. Bruno, Alex Morriss-Andrews, Andrew R. Henderson, Charles L. BrooksIIIIII & Anna K. Mapp. (2016) A Synthetic Loop Replacement Peptide That Blocks Canonical NF-κB Signaling. Angewandte Chemie 128:48, pages 15221-15225.
Crossref
Yunes Panahi, Behrad Darvishi, Mostafa Ghanei, Narges Jowzi, Fatemeh Beiraghdar & Behrang Shiri Varnamkhasti. (2016) Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway. Cytokine & Growth Factor Reviews 28, pages 21-29.
Crossref
Özge Berrak, Yunus Akkoç, Elif Damla Arısan, Ajda Çoker-Gürkan, Pınar Obakan-Yerlikaya & Narçin Palavan-Ünsal. (2016) The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells. Biomedicine & Pharmacotherapy 77, pages 150-160.
Crossref
Ellen Niederberger. 2016. Compendium of Inflammatory Diseases. Compendium of Inflammatory Diseases 604 612 .
Karunakar Saamarthy, Sofie Björner, Martin Johansson, Göran Landberg, Ramin Massoumi, Karin Jirström & Katarzyna Chmielarska Masoumi. (2015) Early diagnostic value of Bcl-3 localization in colorectal cancer. BMC Cancer 15:1.
Crossref
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia Kottorou, Stella Marousi, Ioulia Koukourikou, Melpomeni Kalofonou, Nikolaos Panagopoulos, Chrisoula Scopa, Dimitrios Dougenis, Helen Papadaki, Athanasios G. Papavassiliou & Haralabos P. Kalofonos. (2015) Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients. Lung Cancer 89:3, pages 311-319.
Crossref
Feng Li, Jingwen Zhang, Frank Arfuso, Arunachalam Chinnathambi, M. E. Zayed, Sulaiman Ali Alharbi, Alan Prem Kumar, Kwang Seok Ahn & Gautam Sethi. (2015) NF-κB in cancer therapy. Archives of Toxicology 89:5, pages 711-731.
Crossref
Radhika Loganathan, Ammu K. Radhakrishnan, Kanga Rani Selvaduray & Kalanithi Nesaretnam. (2015) Selective anti-cancer effects of palm phytonutrients on human breast cancer cells. RSC Advances 5:3, pages 1745-1753.
Crossref
Marybeth A. Pysz, Fang Hao, A. Asli Hizli, Michelle A. Lum, Wendy M. Swetzig, Adrian R. Black & Jennifer D. Black. (2014) Differential Regulation of Cyclin D1 Expression by Protein Kinase C α and ϵ Signaling in Intestinal Epithelial Cells. Journal of Biological Chemistry 289:32, pages 22268-22283.
Crossref
Guang YangClyde J. WrightMaurice D. HinsonAmal P. FernandoShaon SenguptaChhanda BiswasPing LaPhyllis A. Dennery. (2014) Oxidative Stress and Inflammation Modulate Rev-erbα Signaling in the Neonatal Lung and Affect Circadian Rhythmicity. Antioxidants & Redox Signaling 21:1, pages 17-32.
Crossref
H. Wolden-KirkD. RondasM. BuglianiH. KorfL. Van LommelK. BrusgaardH.T. ChristesenF. SchuitP. ProostM. MasiniP. MarchettiD.L. Eizirik, L. OverberghC. Mathieu. (2014) Discovery of Molecular Pathways Mediating 1,25-Dihydroxyvitamin D3 Protection Against Cytokine-Induced Inflammation and Damage of Human and Male Mouse Islets of Langerhans. Endocrinology 155:3, pages 736-747.
Crossref
Adeline C. LedouxNeil D. Perkins. (2014) NF-κB and the cell cycle. Biochemical Society Transactions 42:1, pages 76-81.
Crossref
Seemana Bhattacharya & Mrinal Kanti Ghosh. (2014) Cell Death and Deubiquitinases: Perspectives in Cancer. BioMed Research International 2014, pages 1-19.
Crossref
Ahmet Ay & Necmettin Yildirim. (2014) Dynamics matter: differences and similarities between alternatively designed mechanisms. Mol. BioSyst. 10:7, pages 1948-1957.
Crossref
Ellen Niederberger. 2015. Encyclopedia of Inflammatory Diseases. Encyclopedia of Inflammatory Diseases 1 10 .
Willscott E. Naugler & Michael Karin. 2015. Molecular Oncology. Molecular Oncology 336 352 .
Xiaoren Zhang, Andrea Paun, Estefania Claudio, Hongshan Wang & Ulrich Siebenlist. (2013) The Tumor Promoter and NF-κB Modulator Bcl-3 Regulates Splenic B Cell Development. The Journal of Immunology 191:12, pages 5984-5992.
Crossref
Sabine Becker-Weimann, Gaofeng Xiong, Saori Furuta, Ju Han, Irene Kuhn, Uri-David Akavia, Dana Pe’er, Mina J Bissell & Ren Xu. (2013) NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals. Oncotarget 4:11, pages 2010-2020.
Crossref
Ingrid García, Gabriela Cosío, Floria Lizárraga, Gustavo Martínez-Ruiz, Jorge Meléndez-Zajgla, Gisela Ceballos, Magali Espinosa, Rosario Pacheco & Vilma Maldonado. (2013) Bcl-3 regulates UVB-induced apoptosis. Human Cell 26:2, pages 47-55.
Crossref
Nagalakshmi Nadiminty, Ramakumar Tummala, Yezi Zhu & Allen C. Gao. 2013. Prostate Cancer. Prostate Cancer 257 273 .
Vivien Ya-Fan Wang, Wendy Huang, Masataka Asagiri, Nathanael Spann, Alexander Hoffmann, Christopher Glass & Gourisankar Ghosh. (2012) The Transcriptional Specificity of NF-κB Dimers Is Coded within the κB DNA Response Elements. Cell Reports 2:4, pages 824-839.
Crossref
Michael Hinz, Seda Çöl Arslan & Claus Scheidereit. (2012) It takes two to tango: IκBs, the multifunctional partners of NF-κB. Immunological Reviews 246:1, pages 59-76.
Crossref
Albert S. Baldwin. (2012) Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer. Immunological Reviews 246:1, pages 327-345.
Crossref
Anna Maria Malfitano, Chiara Laezza, Mario Galgani, Giuseppe Matarese, Alba D’Alessandro, Patrizia Gazzerro & Maurizio Bifulco. (2012) The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. Pharmacological Research 65:3, pages 365-371.
Crossref
Matthew S. Hayden & Sankar Ghosh. (2012) NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes & Development 26:3, pages 203-234.
Crossref
Neil D. Perkins. (2012) The diverse and complex roles of NF-κB subunits in cancer. Nature Reviews Cancer 12:2, pages 121-132.
Crossref
Tetsuo Mitsui, Maho Ishida, Michi Izawa, Yoshihiro Kagami & Jun Arita. (2011) Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture. Molecular and Cellular Endocrinology 345:1-2, pages 68-78.
Crossref
Zhi-yi Guo, Xiao-hui Hao, Fei-Fei Tan, Xin Pei, Li-Mei Shang, Xue-lian Jiang & Fang Yang. (2011) The elements of human cyclin D1 promoter and regulation involved. Clinical Epigenetics 2:2, pages 63-76.
Crossref
Yi Guan, Hailan Yao, Zhihong Zheng, Guangrong Qiu & Kailai Sun. (2010) MiR‐125b targets BCL3 and suppresses ovarian cancer proliferation . International Journal of Cancer 128:10, pages 2274-2283.
Crossref
Frédéric Pène, Andrea Paun, Søren Ulrik Sønder, Nimisha Rikhi, Hongshan Wang, Estefania Claudio & Ulrich Siebenlist. (2011) The IκB Family Member Bcl-3 Coordinates the Pulmonary Defense against Klebsiella pneumoniae Infection . The Journal of Immunology 186:4, pages 2412-2421.
Crossref
Vilma Maldonado & Jorge Melendez-Zajgla. (2011) Role of Bcl-3 in solid tumors. Molecular Cancer 10:1, pages 152.
Crossref
Jennifer M. Peterson, Nadine Bakkar & Denis C. Guttridge. 2011. Myogenesis. Myogenesis 85 119 .
Ruben Zamora, Magali Espinosa, Gisela Ceballos-Cancino, Blanca Segura, Vilma Maldonado & Jorge Melendez-Zajgla. (2010) Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells. Molecular Cancer 9:1.
Crossref
Kousuke Saito, Mineki Saito, Naoko Taniura, Takako Okuwa & Yoshiro Ohara. (2010) Activation of the PI3K–Akt pathway by human T cell leukemia virus type 1 (HTLV-1) oncoprotein Tax increases Bcl3 expression, which is associated with enhanced growth of HTLV-1-infected T cells. Virology 403:2, pages 173-180.
Crossref
Deilson Elgui de Oliveira, Gianna Ballon & Ethel Cesarman. (2010) NF-κB signaling modulation by EBV and KSHV. Trends in Microbiology 18:6, pages 248-257.
Crossref
James G. Tidball & S. Armando Villalta. (2010) Regulatory interactions between muscle and the immune system during muscle regeneration. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 298:5, pages R1173-R1187.
Crossref
Y-M Kim, T R Geiger, D I Egan, N Sharma & J K Nyborg. (2010) The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene 29:14, pages 2142-2152.
Crossref
Nadine Bakkar & Denis C. Guttridge. (2010) NF-κB Signaling: A Tale of Two Pathways in Skeletal Myogenesis. Physiological Reviews 90:2, pages 495-511.
Crossref
Sahdeo Prasad, Jayaraj Ravindran & Bharat B. Aggarwal. (2009) NF-κB and cancer: how intimate is this relationship. Molecular and Cellular Biochemistry 336:1-2, pages 25-37.
Crossref
Ini-Isabée WitzelLi Fang Koh & Neil D. Perkins. (2010) Regulation of cyclin D1 gene expression. Biochemical Society Transactions 38:1, pages 217-222.
Crossref
Joseph J. Sacco, Judy M. Coulson, Michael J. Clague & Sylvie Urbé. (2010) Emerging roles of deubiquitinases in cancer-associated pathways. IUBMB Life, pages NA-NA.
Crossref
H-L Huang, W-C Yeh, M-Z Lai, C Mirtsos, H Chau, C-H Chou & S Benchimol. (2009) Impaired TNFα-induced A20 expression in E1A/Ras-transformed cells. British Journal of Cancer 101:9, pages 1555-1564.
Crossref
Shafiq Uddin Ahmed & Jo Milner. (2009) Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network. PLoS ONE 4:10, pages e7305.
Crossref
Amanda S. Büchau, Daniel T. MacLeod, Shin Morizane, Paul F. Kotol, Tissa Hata & Richard L. Gallo. (2009) Bcl-3 Acts as an Innate Immune Modulator by Controlling Antimicrobial Responses in Keratinocytes. Journal of Investigative Dermatology 129:9, pages 2148-2155.
Crossref
Kashif Aziz Khan, Alain Coaquette, Christian Davrinche & Georges Herbein. (2009) Bcl-3-Regulated Transcription from Major Immediate-Early Promoter of Human Cytomegalovirus in Monocyte-Derived Macrophages. The Journal of Immunology 182:12, pages 7784-7794.
Crossref
Raza Malik, Anton Bungay, Amama Sadiq, David Brown, Marc Riemann, Sarah Choudhury, Roland Schmid, Clare Selden & Humphrey Hodgson. (2009) The Role of the Bcl-3 Proto-Oncogene in Thyroid Hormone-Induced Liver Cell Proliferation. Artificial Organs 33:6, pages 425-430.
Crossref
Jessica E. Hutti, Rhine R. Shen, Derek W. Abbott, Alicia Y. Zhou, Kam M. Sprott, John M. Asara, William C. Hahn & Lewis C. Cantley. (2009) Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation. Molecular Cell 34:4, pages 461-472.
Crossref
Sivakumar VallabhapurapuMichael Karin. (2009) Regulation and Function of NF-κB Transcription Factors in the Immune System. Annual Review of Immunology 27:1, pages 693-733.
Crossref
Arun K. Mankan, Matthew W. Lawless, Steven G. Gray, Dermot Kelleher & Ross McManus. (2009) NF-κB regulation: the nuclear response. Journal of Cellular and Molecular Medicine 13:4, pages 631-643.
Crossref
Silvia Cristofanon, Franck Morceau, Ivana Scovassi, Mario Dicato, Lina Ghibelli & Marc Diederich. (2008) Oxidative, multistep activation of the noncanonical NF‐κB pathway via disulfide Bcl‐3/p50 complex . The FASEB Journal 23:1, pages 45-57.
Crossref
Yuanjie Sun, Joo-Hyun Lee, Nam-Ho Kim, Chang-Wook Lee, Min-Ju Kim, Seung-Hyuk Kim & Sung-Oh Huh. (2009) Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1791:1, pages 61-68.
Crossref
Marianna Penzo, Paul E. Massa, Eleonora Olivotto, Francesca Bianchi, Rosa Maria Borzi, Adedayo Hanidu, Xiang Li, Jun Li & Kenneth B. Marcu. (2009) Sustained NF-κB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1. Journal of Cellular Physiology 218:1, pages 215-227.
Crossref
Jason M. Dahlman, Jingxin Wang, Nadine Bakkar & Denis C. Guttridge. (2009) The RelA/p65 subunit of NF-κB specifically regulates cyclin D1 protein stability: Implications for cell cycle withdrawal and skeletal myogenesis. Journal of Cellular Biochemistry 106:1, pages 42-51.
Crossref
Young-Mi Kim, Neelam Sharma & Jennifer K. Nyborg. (2008) The Proto-Oncogene Bcl3, Induced by Tax, Represses Tax-Mediated Transcription via p300 Displacement from the Human T-Cell Leukemia Virus Type 1 Promoter. Journal of Virology 82:23, pages 11939-11947.
Crossref
Svetla Rangelova, Susanne Kirschnek, Andreas Strasser & Georg Häcker. (2008) FADD and the NF-κB family member Bcl-3 regulate complementary pathways to control T-cell survival and proliferation. Immunology 125:4, pages 549-557.
Crossref
Sankar Ghosh & Matthew S. Hayden. (2008) New regulators of NF-κB in inflammation. Nature Reviews Immunology 8:11, pages 837-848.
Crossref
Scott Palmer & Youhai H. Chen. (2008) Bcl-3, a multifaceted modulator of NF-κB-mediated gene transcription. Immunologic Research 42:1-3, pages 210-218.
Crossref
Christine A. Goetz & Albert S. Baldwin. (2008) NF-κB pathways in the immune system: control of the germinal center reaction. Immunologic Research 41:3, pages 233-247.
Crossref
Chengyin Min, Sean F. Eddy, David H. Sherr & Gail E. Sonenshein. (2008) NF-κB and epithelial to mesenchymal transition of cancer. Journal of Cellular Biochemistry 104:3, pages 733-744.
Crossref
Pascal DescarguesAlok K. SilYuji SanoOlexandr Korchynskyi, Gangwen Han, Philip Owens, Xiao-Jing Wang & Michael Karin. (2008) IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proceedings of the National Academy of Sciences 105:7, pages 2487-2492.
Crossref
Hiroyuki Nakamura, Chihiro Ishii, Masakazu Suehiro, Akifumi Iguchi, Kazumichi Kuroda, Kazufumi Shimizu, Norio Shimizu, Ken-Ichi Imadome, Misako Yajima & Shigeyoshi Fujiwara. (2008) The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-κB. Virus Research 131:2, pages 170-179.
Crossref
Matthew S. Hayden & Sankar Ghosh. (2008) Shared Principles in NF-κB Signaling. Cell 132:3, pages 344-362.
Crossref
Gautam Sethi, Bokyung Sung & Bharat B. Aggarwal. (2008) Nuclear Factor-κB Activation: From Bench to Bedside. Experimental Biology and Medicine 233:1, pages 21-31.
Crossref
Natalie J. Thornburg & Nancy Raab-Traub. (2007) Induction of Epidermal Growth Factor Receptor Expression by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal-Activating Region 1 Is Mediated by NF-κB p50 Homodimer/Bcl-3 Complexes. Journal of Virology 81:23, pages 12954-12961.
Crossref
Benjamin Barré & Neil D Perkins. (2007) A cell cycle regulatory network controlling NF-κB subunit activity and function. The EMBO Journal 26:23, pages 4841-4855.
Crossref
Jun-ichi Abe. (2007) Role of PKCs and NF-κB activation in myocardial inflammation: Enemy or ally?. Journal of Molecular and Cellular Cardiology 43:4, pages 404-408.
Crossref
Carter Van Waes. (2007) Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer. Clinical Cancer Research 13:4, pages 1076-1082.
Crossref
Masashi Ozeki, Yuki Hamajima, Ling Feng, Frank G. Ondrey, Eileen Schlentz & Jizhen Lin. (2007) Id1 induces the proliferation of cochlear sensory epithelial cells via the nuclear factor-κB/cyclin D1 pathway in vitro. Journal of Neuroscience Research 85:3, pages 515-524.
Crossref
Jiping Zhang, Mary Ann Warren, Suzanne F. Shoemaker & Margot M. Ip. (2007) NFκB1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NFκB2/p52 and RelB. Endocrinology 148:1, pages 268-278.
Crossref
Neil D. Perkins. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nature Reviews Molecular Cell Biology 8:1, pages 49-62.
Crossref
D S Bassères & A S Baldwin. (2006) Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25:51, pages 6817-6830.
Crossref
G Courtois & T D Gilmore. (2006) Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25:51, pages 6831-6843.
Crossref
Claus Scheidereit. (2006) IκB kinase complexes: gateways to NF-κB activation and transcription. Oncogene 25:51, pages 6685-6705.
Crossref
Sung Gyoo Park, Chan Chung, Hang Kang, Ji-Yeon Kim & Guhung Jung. (2006) Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter. Journal of Biological Chemistry 281:42, pages 31770-31777.
Crossref
Katie Schumm, Sonia Rocha, Jorge Caamano & Neil D Perkins. (2006) Regulation of p53 tumour suppressor target gene expression by the p52 NF-κB subunit. The EMBO Journal 25:20, pages 4820-4832.
Crossref
Emmanuel Dejardin. (2006) The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development. Biochemical Pharmacology 72:9, pages 1161-1179.
Crossref
Sung Gyoo Park, Chan Chung, Hang Kang, Ji-Yeon Kim & Guhung Jung. (2006) Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter. Journal of Biological Chemistry 281:42, pages 31770-31777.
Crossref
Jean-Simon Diallo, Benjamin Péant, Laurent Lessard, Nathalie Delvoye, Cécile Le Page, Anne-Marie Mes-Masson & Fred Saad. (2006) An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines. The Prostate 66:12, pages 1245-1256.
Crossref
Gudrun Totzke, Frank Essmann, Stephan Pohlmann, Charlotte Lindenblatt, Reiner U. Jänicke & Klaus Schulze-Osthoff. (2006) A Novel Member of the IκB Family, Human IκB-ζ, Inhibits Transactivation of p65 and Its DNA Binding. Journal of Biological Chemistry 281:18, pages 12645-12654.
Crossref
Ramin Massoumi, Katarzyna Chmielarska, Katharina Hennecke, Alexander Pfeifer & Reinhard Fässler. (2006) Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling. Cell 125:4, pages 665-677.
Crossref
M F Rubio, S Werbajh, E G A Cafferata, A Quaglino, G P Coló, I M Nojek, E C Kordon, V E Nahmod & M A Costas. (2005) TNF-α enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Oncogene 25:9, pages 1367-1377.
Crossref
David Kashatus, Patricia Cogswell & Albert S. Baldwin. (2006) Expression of the Bcl-3 proto-oncogene suppresses p53 activation. Genes & Development 20:2, pages 225-235.
Crossref
Pei Yen Yeh, Sung-Hsin Kuo, Kun-Huei Yeh, Shuang-En Chuang, Chih-Hung Hsu, Wen Ching Chang, Hsin-I Lin, Ming Gao & Ann-Lii Cheng. (2006) A Pathway for Tumor Necrosis Factor-α-induced Bcl10 Nuclear Translocation. Journal of Biological Chemistry 281:1, pages 167-175.
Crossref
Elaine J. Schattner, Richard R. Furman & Alejandro Bernal. 2006. NF-κB/Rel Transcription Factor Family. NF-κB/Rel Transcription Factor Family 131 146 .
Stephan MathasKorinna JöhrensStefan JoosAndreas LietzFranziska HummelMartin JanzFranziska JundtIoannis AnagnostopoulosKurt BommertPeter LichterHarald SteinClaus ScheidereitBernd Dörken. (2005) Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood 106:13, pages 4287-4293.
Crossref
Shishir Shishodia, Hesham M. Amin, Raymond Lai & Bharat B. Aggarwal. (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochemical Pharmacology 70:5, pages 700-713.
Crossref
Yujie Zhao, Aravind Ramakrishnan, Kyoung-Eun Kim & Arnold B. Rabson. (2005) Regulation of Bcl-3 through interaction with the Lck tyrosine kinase. Biochemical and Biophysical Research Communications 335:3, pages 865-873.
Crossref
Xavier Dolcet, David Llobet, Judit Pallares & Xavier Matias-Guiu. (2005) NF-kB in development and progression of human cancer. Virchows Archiv 446:5, pages 475-482.
Crossref
Ellen Schlette, George Z. Rassidakis, Ozlem Canoz & L. Jeffrey Medeiros. (2005) Expression of bcl-3 in Chronic Lymphocytic Leukemia Correlates With Trisomy 12 and Abnormalities of Chromosome 19. American Journal of Clinical Pathology 123:3, pages 465-471.
Crossref
N.D. Perkins. (2004) Regulation of NF-κB by atypical activators and tumour suppressors. Biochemical Society Transactions 32:6, pages 936-939.
Crossref
Paul W. BatesShigeki Miyamoto. (2004) Expanded Nuclear Roles for IκBs. Science's STKE 2004:254.
Crossref
Jamie E. Hoberg, Fan Yeung & Marty W. Mayo. (2004) SMRT Derepression by the IκB Kinase α. Molecular Cell 16:2, pages 245-255.
Crossref
Patrick Viatour, Emmanuel Dejardin, Michael Warnier, Florence Lair, Estefania Claudio, Fabrice Bureau, Jean-Christophe Marine, Marie-Paule Merville, Ulrich Maurer, Douglas Green, Jacques Piette, Ulrich Siebenlist, Vincent Bours & Alain Chariot. (2004) GSK3-Mediated BCL-3 Phosphorylation Modulates Its Degradation and Its Oncogenicity. Molecular Cell 16:1, pages 35-45.
Crossref
Sören BEINKESteven C. LEY. (2004) Functions of NF-κB1 and NF-κB2 in immune cell biology. Biochemical Journal 382:2, pages 393-409.
Crossref
Violaine Sée, Nina K.M. Rajala, David G. Spiller & Michael R.H. White. (2004) Calcium-dependent regulation of the cell cycle via a novel MAPK–NF-κB pathway in Swiss 3T3 cells. Journal of Cell Biology 166:5, pages 661-672.
Crossref
Ozlem Canoz, George Z Rassidakis, Joan H Admirand & L Jeffrey Medeiros. (2004) Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases. Modern Pathology 17:8, pages 911-917.
Crossref
Floria Lizárraga, Vilma Maldonado & Jorge Meléndez-Zajgla. (2004) Tissue inhibitor of metalloproteinases-2 growth-stimulatory activity is mediated by nuclear factor-kappa B in A549 lung epithelial cells. The International Journal of Biochemistry & Cell Biology 36:8, pages 1655-1663.
Crossref
Lin-Feng Chen & Warner C. Greene. (2004) Shaping the nuclear action of NF-κB. Nature Reviews Molecular Cell Biology 5:5, pages 392-401.
Crossref
Neil D. Perkins. (2004) NF-κB: tumor promoter or suppressor?. Trends in Cell Biology 14:2, pages 64-69.
Crossref
Chenguan Wang, Zhiping Li, Maofu Fu, Toula Bouras & Richard G. Pestell. 2004. Molecular Targeting and Signal Transduction. Molecular Targeting and Signal Transduction 217 237 .
Thomas D. Gilmore. 2004. Signal Transduction in Cancer. Signal Transduction in Cancer 241 265 .
Jérôme Kucharczak, Matthew J Simmons, Yongjun Fan & Céline Gélinas. (2003) To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosis. Oncogene 22:56, pages 8961-8982.
Crossref
Neil D Perkins. (2003) Oncogenes, tumor suppressors and p52 NF-κB. Oncogene 22:48, pages 7553-7556.
Crossref
Aristides G Eliopoulos, Jorge H Caamano, Joanne Flavell, Gary M Reynolds, Paul G Murray, Jean-Luc Poyet & Lawrence S Young. (2003) Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway. Oncogene 22:48, pages 7557-7569.
Crossref
P Viatour, M Bentires-Alj, A Chariot, V Deregowski, L de Leval, M-P Merville & V Bours. (2003) NF-κB2/p100 induces Bcl-2 expression. Leukemia 17:7, pages 1349-1356.
Crossref
Alok C. BhartiNicholas DonatoSujay SinghBharat B. Aggarwal. (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101:3, pages 1053-1062.
Crossref
A. S. BaldwinJr.Jr.. 2003. Nuclear Factor кB. Nuclear Factor кB 393 408 .
THOMAS C. MITCHELL, BRUCE S. THOMPSON, JOHN O. TRENT & CAROLYN R. CASELLA. (2002) A Short Domain within Bcl-3 Is Responsible for Its Lymphocyte Survival Activity. Annals of the New York Academy of Sciences 975:1, pages 132-147.
Crossref
MJS Dyer & DG Oscier. (2002) The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 16:6, pages 973-984.
Crossref
Sébastien Jeay, Gail E. Sonenshein, Marie-Catherine Postel-Vinay, Paul A. Kelly & Elena Baixeras. (2002) Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Molecular and Cellular Endocrinology 188:1-2, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.